What is a clinical trial for cancer?
A clinical trial is a research study in which volunteers help doctors learn whether a new way of preventing, finding or treating cancer works, and what side effects it may have. It can test a new medicine, a new combination of treatments, or a new way of giving surgery or radiotherapy.
Trials are one of the main ways medical knowledge moves forward. Every trial follows a written plan and is reviewed before it starts. People join by choice, and a person who is thinking about it can ask as many questions as they need. Taking part is not right or wrong for everyone, and it varies by cancer type and situation. Some trials compare a new approach with the usual treatment, so you may not receive the new approach. Your oncologist can tell you whether a trial is worth discussing, and the trial team explains how the study works.
What are the phases of a clinical trial?
Trials are run in steps called phases. Phase 1 mainly looks at how a treatment is tolerated and what side effects it causes. Phase 2 asks whether the treatment shows promise against a particular type of cancer. Phase 3 compares the new approach with the usual treatment, usually in larger groups of people. Phase 4 happens after a treatment is approved, to learn more about its use over a longer time.
The phase tells you how much is already known. In the early phases, less is known about benefits and side effects, so the trial team watches closely. The details of each phase vary by trial. When the app explains a trial, the phase may be mentioned in plain words. Ask your oncologist what the phase means for you, and ask the trial team how the study will be run.
What are the usual rules for joining a cancer clinical trial?
Each trial has its own rules, called eligibility criteria, about who can take part. Often these cover the type and stage of cancer, what treatment has been given before, certain test results, general health and other medical conditions. Some rules decide who can join, and others decide who cannot.
The rules exist to answer the research question properly and to protect the people taking part. A person may meet some rules but not others, and the trial team checks each one, often with their own tests. This is why OncoVOIS says a trial "may fit" and never "eligible". The app reads your confirmed reports and suggests trials worth discussing, but only the trial team can decide whether you can join. If you do not meet the rules of one trial, that says nothing about other trials. Ask your oncologist what else may be worth discussing.
Are clinical trials in India regulated?
Yes. Clinical trials in India follow national rules, and a trial needs approval from an ethics committee before it can begin. An ethics committee is an independent group that checks that a study is fair, that the plan is reasonable, and that people taking part are properly informed and looked after.
In practice, this means a trial has a written plan, a patient information sheet and a consent form that you can read before you decide. The trial team explains the details to you, including the purpose, what will happen, the possible risks and what is expected of you. Rules can change over time, so the hospital's help desk or the trial team is the right place to confirm the current details for a particular study. If anything seems unclear, ask for it to be explained again in your own language, and ask your oncologist if it is worth taking part.
What is informed consent in a clinical trial?
Informed consent means you agree to take part only after the trial team has explained the study and you have understood it. You are asked to read and sign a consent form to show this.
The explanation usually covers why the study is being done, what will happen to you, how long it lasts, the possible risks and benefits, other options you have and who to contact with questions. You can ask for the form in a language you understand, take it home, and discuss it with family and your oncologist before deciding. There is no need to rush. Signing is not the end of the conversation either, because you can ask questions at any time during the study. If anything in the form is unclear, ask the trial team to go through it again. Your oncologist can help you think about what to ask.
Will I get a placebo instead of real treatment in a cancer trial?
It depends on the trial. A placebo is a look-alike treatment with no active medicine in it. In many cancer trials, the new approach is compared with the usual treatment, not with nothing. When a placebo is used, it is often given together with the usual treatment, but this varies by trial.
Some trials use randomisation, which means chance decides which group you are in, so that the groups can be compared fairly. The trial team must tell you before you join whether a placebo is used, how groups are chosen, and whether you will be told which group you are in. Ask them directly, and ask your oncologist what the usual treatment would be for you outside the trial. The answer differs from one study to another, so it is worth getting it in writing in the patient information sheet and asking about anything that is not clear.
Can I leave a clinical trial after I join?
Taking part in a trial is voluntary. The consent process explains that a person may choose to stop. Before you decide, ask the trial team how leaving works, what follow-up is needed and what care would follow.
If you are thinking of leaving, speak to the trial team and your oncologist first, so that the next steps in your treatment can be planned. Do not stop any medicine on your own. People leave for many reasons, such as side effects, travel, family circumstances or a change of mind, and the team has usually heard these before. It can help to write your reasons down and to bring a family member to the conversation. Remember that you can ask questions at any stage, not only before joining. If you feel very unwell, contact your hospital or call 112, or 108 for an ambulance, and do not wait.
What does taking part in a clinical trial involve day to day?
It depends on the trial, and the trial team will explain it before you agree to join. In general, taking part means following a set plan: visits at the hospital or trial centre, tests and scans at fixed times, taking the trial treatment as directed, and reporting any side effects or changes in how you feel.
The plan is written in a document called the protocol, and the main points are given to you in the consent form. Ask how often you will need to attend, how long the visits take, how long the trial lasts, and what follow-up comes afterwards. Also ask whether the visits can fit with your work, family and travel, and who you should call if something worries you between visits. You can ask for time to think, and to talk to your family and your own oncologist, before deciding. Joining is always your choice, and you can ask questions at any point.
What is a clinical trial protocol and why does it matter?
A protocol is the written plan for a clinical trial. It explains why the study is being done, who can take part, which treatments and tests are involved, how often visits happen, how side effects are watched and what the researchers will measure.
The protocol is reviewed by an ethics committee before the trial starts, and everyone running the study follows it. As a patient, you will not usually be given the whole protocol, as it is long and technical. Instead, you receive a patient information sheet that explains the main points in simpler language, and you can ask the trial team to go through anything you do not understand. Knowing that every trial follows a plan helps explain why the rules about who can join are strict, and why visits and tests are fixed in advance. Your oncologist can help you read the sheet and decide what to ask.